探索复制压力和细胞衰老作为新型癌症疗法的关键标
Suman Kumar Ray1, Sukhes Mukherjee1
1Department of Biochemistry. All India Institute of Medical Sciences. Bhopal, Madhya Pradesh 462020. India.
Cancer genetics
|September 11, 2025
概括
持续的复制压力是DNA损伤和癌症发展的关键因素,与细胞衰老密切相关. 了解这种联系可能会导致针对关键途径的新型癌症疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 癌症的特点是持续的细胞增殖,逃避细胞灭绝和遗传不稳定.
- 由DNA损伤引起的复制压力导致基因组不稳定,在癌前和癌细胞中观察到.
- 细胞衰老是一种保护机制,可以阻止受损或衰老细胞的细胞循环.
研究的目的:
- 审查癌症发生过程中持续复制压力和细胞衰老之间的关系.
- 提供有关瘤发生的早期阶段的见解.
- 为开发新的癌症诊断和治疗策略提供信息.
主要方法:
- 本综述审查了关于复制应激和细胞衰老的现有文献.
- 它探讨了瘤基因在诱导复制应激中的作用.
- 该综述讨论了复制应激反应途径中的潜在治疗点.
主要成果:
- 复制压力是癌症发展的早期阶段,通常由瘤基因诱导.
- 细胞衰老可以由瘤基因过度表达引发,作为瘤抑制机制.
- 持续的复制压力和细胞衰老在致癌过程中相互关联.
结论:
- 研究复制应激反应为新的癌症疗法提供了潜力.
- 针对Chk1,ATR和PARP等途径可能产生有效的小分子抑制剂.
- 了解复制压力和衰老之间的相互作用对于早期癌症检测和治疗至关重要.
相关概念视频
Replicative Cell Senescence
4.3K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.3K
DNA Damage Can Stall the Cell Cycle
3.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
DNA Damage can Stall the Cell Cycle
10.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.0K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


